Caplan sees a host of bioethical turning points coming out of the pandemic

The reckoning that will come after the pandemic will see broad if not tectonic shifts in drug development, from clinical trial conduct to scientific publishing, according to bioethicist Arthur Caplan. The botched rollout of vaccines has lessons too.

In an interview with BioCentury, Caplan, head of the division of medical ethics at New York University School of Medicine, said the lagging distribution of vaccines in the U.S. and the U.K., in contrast to the much-lauded program in Israel, demonstrates the value of an integrated healthcare system and the importance of coupling that with a coordinated government strategy. ...